IMMUNOME INC (IMNM)
Sector: Health Care
Named Executive Officers
Compensation data for top executives (showing up to 3 years of data)
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Clay Siegall, Ph.D. President, Chief Executive Officer and Chairman of the Board | 2025 | $735,000 | $0 | $0 | $6,272,810 | $661,500 | $13,291 | $7,682,601 |
| 2024 | $700,000 | $0 | $0 | $7,991,424 | $525,000 | $10,350 | $9,226,774 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Max Rosett Chief Financial Officer | 2025 | $472,500 | $0 | $0 | $1,623,090 | $278,800 | $411,167 | $2,785,557 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Robert Lechleider, M.D. Chief Medical Officer | 2025 | $530,300 | $0 | $0 | $1,897,525 | $307,600 | $12,193 | $2,747,618 |